Arena Pharmaceuticals (ARNA) Lifts Ahead of Tomorrow's BELVIQ Launch
Get Alerts ARNA Hot Sheet
Join SI Premium – FREE
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is up 1% early Thursday ahead of the launch of its key obesity drug BELVIQ tomorrow. More
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Trump admin taps former JPMorgan Chase exec Matt Zames to advise social security agency - CNBC
Create E-mail Alert Related Categories
FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share